Harvard Management Company’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Harvard Management Company’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,000	Closed	-$3.23M	–	80
2016 Q4	$3.23M	Sell	30,000 -10,000	-25%	-$1.17M	0.49%	32
2016 Q3	$4.98M	Sell	40,000 -300	-0.7%	-$35.4K	0.79%	26
2016 Q2	$4.29M	Sell	40,300 -10,000	-20%	-$1.16M	0.83%	25
2016 Q1	$5.76M	Buy	50,300 +35,000	+229%	+$4.11M	0.42%	37
2015 Q4	$2.18M	Hold	15,300	–	–	0.21%	70
2015 Q3	$1.37M	Sell	15,300 -2,534	-14%	-$267K	0.11%	90
2015 Q2	$2.05M	Buy	+17,834	New	+$1.87M	0.17%	81

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Harvard Management Company's CBPO Position: Q1 2017 in Review

Harvard Management Company sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 30,000 shares — an estimated $3.23M sold.

Harvard Management Company first reported a position in CBPO in Q2 2015 and held it in 7 quarters. The position peaked at $5.76M in Q1 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Harvard Management Company reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Harvard Management Company sold 30,000 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $3.23M.
Harvard Management Company first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 7 quarters.
Harvard Management Company's China Biologic Products Holdings, Inc. position peaked at $5.76M in Q1 2016.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Harvard Management Company's 13F filing for Q1 2017, filed 12 May 2017.